ArticleJournal of applied clinical medical physics2026
Implementation of VMAT-based lattice spatially fractionated radiation therapy (SFRT) across linac platforms: Practical considerations for QA and motion management.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpatially fractionated radiation therapy (SFRT) offers a method to treat bulky, radioresistant tumors while sparing normal tissues. Modern volumetric modulated arc therapy (VMAT) delivery enables conformal lattice SFRT plans, but practical guidance for implementation across different linear accelerators is limited. PURPOSE: This study presents a structured clinical workflow for implementing lattice SFRT across Edge and Halcyon linacs, with emphasis on quality assurance (QA) and motion management.
methodsA systematic workflow was developed using Eclipse TPS (Acuros v16) with 6 MV flattening filter-free (FFF) beams and applied to Edge and Halcyon linacs. The implementation progressed from 28 preliminary phantom and test plans to 12 representative clinical test plans across head and neck, pelvis, and extremity sites, and 6 lung plans evaluating respiratory motion effects with and without the SDX breath-hold system. Two prescription strategies were investigated: (a) a single-fraction lattice regimen delivering 18 Gy to vertices with valley doses < 6 Gy, and (b) a simultaneous integrated boost (SIB) approach delivering 66.7 Gy to vertices with 20 Gy in 5 fractions to the entire target. Dosimetric accuracy and deliverability were evaluated using Delta4, Electronic Portal Imaging Device (EPID), and film measurements.
resultsVMAT-based lattice SFRT plans were successfully delivered on both linacs with consistent dosimetric performance. Point-based peak-to-valley dose ratios (PVDRs) ranged from 2.8 to 3.4 across the two platforms for both dose prescriptions. Delta4 and EPID gamma pass rates exceeded 90% (3%/1 mm), and film dosimetry agreed within ∼5% uncertainty. Comparable outcomes between Edge and Halcyon support cross-platform reproducibility. In the evaluated lung cases, motion on the order of 5 mm was associated with changes in organ-at-risk (OAR) doses, highlighting the need for motion management.
conclusionsThis structured framework demonstrates that lattice SFRT can be safely implemented across different linac platforms. While dosimetric outcomes are institution-dependent, the method provides practical guidance for clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.